The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ziv-aflibercept (A) combined to FOLFIRI as first line treatment for metastatic colorectal cancer (mCRC): Interim safety and efficacy results of the phase II PULSAR trial.
 
Antoine Adenis
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Sanofi
Research Funding - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Francois Ghiringhelli
No Relationships to Disclose
 
Jean Luc Raoul
Consulting or Advisory Role - Sanofi
Speakers' Bureau - Sanofi
Research Funding - Sanofi
Travel, Accommodations, Expenses - Sanofi
 
Emmanuelle Tresch
No Relationships to Disclose
 
Anne Thirot-Bidault
No Relationships to Disclose
 
Julie Vincent
No Relationships to Disclose
 
Farid El Hajbi
Travel, Accommodations, Expenses - Sanofi
 
Mohamed Hebbar
No Relationships to Disclose
 
Mohamed Bouchahda
No Relationships to Disclose
 
Hajer Jarraya
No Relationships to Disclose
 
Sylvaine Feutray
No Relationships to Disclose
 
Eric Amela
Travel, Accommodations, Expenses - Sanofi
 
Fredrik Laestadius
No Relationships to Disclose
 
Marie-Cécile Le Deley
No Relationships to Disclose
 
Sophie Taieb
No Relationships to Disclose
 
Fabrice Soncin
No Relationships to Disclose
 
Emmanuelle Dochy
No Relationships to Disclose
 
Stephanie Clisant Delaine
No Relationships to Disclose
 
Nicolas Penel
Research Funding - Bayer
 
Nathalie Lassau
No Relationships to Disclose